Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events

BACKGROUND: Epoetin-β is used to treat patients with cancer undergoing chemotherapy to alleviate the symptoms of anaemia, reduce the risk of blood transfusions and improve quality of life (QoL). METHODS: This meta-analysis of all 12 randomised, controlled studies of epoetin-β evaluated the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapro, M, Osterwalder, B, Scherhag, A, Burger, H U
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795449/
https://www.ncbi.nlm.nih.gov/pubmed/19997109
http://dx.doi.org/10.1038/sj.bjc.6605255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795449/
https://www.ncbi.nlm.nih.gov/pubmed/19997109
http://dx.doi.org/10.1038/sj.bjc.6605255

Ejemplares similares